Related Experiment Video
Updated: Apr 15, 2026
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Kidney tumor staging using surface-enhanced Raman scattering
Sevda Mert1, Emin Özbek2, Alper Ötünçtemur2
1Yeditepe University, Department of Genetics and Bioengineering, Faculty of Engineering, Kayisdagi Street, Atasehir, Istanbul 34755, Turkey.
Abstract:
The detection of kidney cancers at an early stage is critical for diagnosis and therapy. Surface-enhanced Raman scattering (SERS) is investigated for early detection of cancer cases from biopsy samples. The colloidal silver nanoparticles as the SERS-active nanostructures are directly mixed with homogenized tissue samples. The SERS spectra from the normal and abnormal tissue samples collected from 40 cancer patients, 28 of them at T1 stage and 12 of them at T2–T3 stages, are analyzed using principal component analysis combined linear discriminant analysis with leave-one-out cross-validation method. It is found that the diagnosis sensitivity, specificity, and total accuracy of the approach can be as high as 100%. The results suggest that SERS can be used as a potential technique for the identification of the different tumor stages.
Insights
Early kidney cancer detection is crucial. Surface-enhanced Raman scattering (SERS) shows 100% accuracy in identifying cancer stages from biopsy samples, offering a promising diagnostic tool.
Area of Science:
- Biomedical Optics
- Nanotechnology
- Oncology
Background:
- Early kidney cancer detection is vital for effective diagnosis and treatment.
- Current diagnostic methods may have limitations in sensitivity for early-stage detection.
- Surface-enhanced Raman scattering (SERS) offers a potential label-free spectroscopic approach.
Purpose of the Study:
- To investigate the efficacy of SERS for the early detection and staging of kidney cancer from biopsy samples.
- To evaluate the diagnostic performance of SERS in distinguishing normal, early-stage, and advanced-stage kidney cancer tissues.
Main Methods:
- Utilized colloidal silver nanoparticles as SERS-active nanostructures.
- Directly mixed nanostructures with homogenized kidney tissue samples.
- Analyzed SERS spectra from 40 patients (28 T1, 12 T2-T3) using PCA-LDA with leave-one-out cross-validation.
Main Results:
- Achieved 100% sensitivity, specificity, and total accuracy in diagnosing kidney cancer.
- Successfully differentiated between normal and cancerous tissue samples.
- Demonstrated capability in identifying different tumor stages (T1 vs. T2-T3).
Conclusions:
- SERS is a highly accurate and sensitive technique for early kidney cancer detection.
- The SERS approach shows potential for non-invasive or minimally invasive cancer staging.
- This method could significantly improve kidney cancer diagnosis and patient management.
